Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Using Dronabinol to Enhance the Analgesic Effect of Hydromorphone in Humans

NCT02901275 is registered in ClinicalTrials.gov with Johns Hopkins University as lead sponsor.

NCT NCT02901275
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02901275 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Using Dronabinol to Enhance the Analgesic Effect of Hydromorphone in Humans
Lead sponsor
Johns Hopkins University
Phase
Phase 2
Overall status
Completed
Start date
December 31, 2016
Completion date
March 23, 2020
Enrollment
29 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cannabis, opioid use, unspecified, pain